Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Immediate implant with bone graft taken from the maxillary tuberosity to improve upper front-tooth esthetics.

Official title: Clinical and Esthetic Outcomes of Immediate Implant Placement With Autogenous Maxillary Tuberosity Graft in the Esthetic Zone: A Prospective Case Series

Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT07460076 · Data updated 2026-11-12

This trial tries placing an implant immediately after extraction and using bone taken from the maxillary tuberosity to improve bone thickness, gum support, and esthetic outcomes for adults needing a single upper front-tooth replacement.

More Alveolar Bone Loss trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City
Academic / other
Locations1 site (Ho Chi Minh City, Ho Chi Minh)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedOctober 2026
Study endsNovember 2026
Registry record updatedMarch 10, 2026
Trial IDNCT07460076 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who need a single implant in the maxillary esthetic zone, are candidates for immediate implant placement, and have a buccal bone defect suitable for augmentation with a maxillary tuberosity autograft.

Probably not a fit

Patients with uncontrolled systemic disease, prior head and neck radiotherapy, active oral infection, heavy smoking, insufficient bone for the planned protocol, or severe parafunctional habits are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective interventional case series combines immediate implant placement in the maxillary esthetic zone with a two-layer autogenous graft harvested from the maxillary tuberosity (cortical bone plus connective tissue). Patients requiring extraction and a single upper-front implant receive the graft at the time of implant placement and are followed with clinical exams and cone-beam CT imaging. Primary outcomes are buccal bone thickness on CBCT, facial soft tissue thickness measured clinically, and the pink esthetic score after definitive restoration. Follow-up assessments will track radiographic and esthetic changes to determine whether the tuberosity graft improves peri-implant tissue stability.

Why it matters

Potential benefit: If successful, this approach could increase buccal bone and soft-tissue support around immediate upper-front implants, improving esthetic scores and long-term stability.

How similar studies have gone: Small case series and clinical reports have reported promising bone and esthetic results with maxillary tuberosity autografts, but high-quality randomized trials are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older
* Patients requiring single implant placement in the maxillary esthetic zone
* Indication for immediate implant placement following tooth extraction
* Presence of a buccal bone defect requiring augmentation with an autogenous maxillary tuberosity bone graft
* Adequate oral hygiene and ability to maintain postoperative care
* Willingness to participate in the study and provide informed consent

Exclusion Criteria:

* Uncontrolled sHistory of radiotherapy in the head and neck region ystemic diseases
* History of radiotherapy in the head and neck region
* Active periodontal disease or untreated oral infection
* Heavy smoking (more than 10 cigarettes per day)
* Pregnancy or lactation
* Severe parafunctional habits
* Insufficient bone volume preventing implant placement with the planned protocol
* Patients unable to attend follow-up visits

Where it's running

  • University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, Ho Chi Minh, Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.